← Leaderboards
Shrinivasan Raghuraman
University Of Utah
$820,664
Attributed
$2,461,992
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $738.6K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,461,992 · 1
By mechanism
R01$2,461,992 · 1
Top collaborators
- Baldomero M Olivera6 shared
- Helena Safavi-Hemami6 shared
Most similar at University Of Utah
Same institution · by research overlap
- Baldomero M Olivera$11,578,852
- Doju Yoshikami$5,612,208
- Chris M. Ireland$5,503,293
- Gary E Keck$5,459,045
- Louis R Barrows$9,079,632
Others in their field
Other Rising Stars on “Imaging Platform”
- Gary Mays · Axle Informatics, Llc$30,383,637
- Ons M'saad · Panluminate Inc.$5,042,916
- Christopher J. Lindsell · Vanderbilt University Medical Center$5,018,091
- Jeff P Simko · Washington University$4,624,354
- Ruben Dries · Boston Medical Center$3,371,645
- Jennifer M. Rosenbluth · University Of California, San Francisco$3,109,407
Research focus
Imaging PlatformMolecular TargetEpilepsyFishesLinkMolecularDiagnosticElectrophysiology (Science)AnimalsFda ApprovedInsightLaboratoriesCalciumBasic ScienceBehaviorClinical TrialsAffectComplexConeBiochemicalBiologicalConus GenusConus VenomNatural Products
Grant awards (6)
âConus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discoveryâ$575,070
R01 · FY2025 · GM
âConus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discoveryâ$575,070
R01 · FY2024 · GM
âConus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discoveryâ$574,453
R01 · FY2023 · GM
âConus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discoveryâ$153,370
R01 · FY2023 · GM
âConus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discoveryâ$10,811
R01 · FY2023 · GM
âConus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discoveryâ$573,218
R01 · FY2022 · GM